Retraction: MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM (PLoS ONE (2014) 9:12 (e114585) DOI: 10.1371/journal.pone.0114585);MicroRNA-503 Acts as a tumor suppressor in osteosarcoma by targeting L1CAM

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Chong, Yang ^a   Zhang, Jie ^a   Guo, Xinzhen ^a   Li, Guojun ^a   Zhang, Shiqian ^a   Li, Chao ^a   Jiao, Zhijian ^a   Shao, Ming ^a   Cheng, Jin Q ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; MICRORNA; MICRORNA 503; UNCLASSIFIED DRUG; MIRN503 MICRORNA, HUMAN; NERVE CELL ADHESION MOLECULE L1;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; ADOLESCENT; CELL MOTION; CHILD; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ADOLESCENT; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHILD; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEURAL CELL ADHESION MOLECULE L1; OSTEOSARCOMA;

EID: 84956694647     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0269900     Document Type: Erratum

References (29)

1. Rainusso N, Wang LL, Yustein JT (2013) The adolescent and young adult with cancer: State of the art - bone tumors. Curr Oncol Rep 15: 296-307.
2. Long XH, Mao JH, Peng AF, Zhou Y, Huang SH, et al. (2013) Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med 5: 1048-1052.
3. Yang J, Zhang W (2013) New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406.
4. Hughes DP (2009) How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res 152: 479-496.
5. Liang W, Gao B, Fu P, Xu S, Qian Y, et al. (2013) The miRNAs in the pathgenesis of osteosarcoma. Front Biosci (Landmark Ed) 18: 788-794.
6. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, et al. (2012) Modulation of the osteosarcoma expression phenotype by micro RNAs. PLoS One 7: e48086.
7. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, et al. (2013) Expression of micro RNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR- 222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 52: 297-303.
8. Zhu W, He J, Chen D, Zhang B, Xu L, et al. (2014) Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer. PLoS One 9: e87780.
9. Kobayashi E, Hornicek FJ, Duan Z (2012) Micro RNA Involvement in Osteosarcoma. Sarcoma 2012: 359739.
10. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, et al. (2012) miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 72: 1865-1877.
11. Chen L, Wang Q, Wang GD, Wang HS, Huang Y, et al. (2013) miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS Lett 587: 1366-1372.
12. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, et al. (2012) Epigenetic mechanisms in gastric cancer. Epigenomics 4: 279-294.
13. Jiang Q, Feng MG, Mo YY (2009) Systematic validation of predicted micro RNAs for cyclin D1. BMC Cancer 9: 194.
14. Wang T, Ge G, Ding Y, Zhou X, Huang Z, et al. (2014) MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2. Chin Med J (Engl) 127: 2357-2362.
15. Xiao F, Zhang W, Chen L, Chen F, Xie H, et al. (2013) MicroRNA-503 inhibits the G1/S transition by down regulating cyclin D3 and E2F3 in hepato cellular carcinoma. J Transl Med 11: 195.
16. Zhou J, Wang W (2011) Analysis of micro RNA expression profiling identifies microRNA-503 regulates metastatic function in hepato cellular cancer cell. J Surg Oncol 104: 278-283.
17. Zhou J, Tao Y, Peng C, Gu P, Wang W (2014) miR-503 regulates metastatic function through Rho guanine nucleotide exchanger factor 19 in hepato cellular carcinoma. J Surg Res 188: 129-136.
18. Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y, et al. (2013) MicroRNA-503 suppresses proliferation and cellcycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. FEBS J 280: 3768-3779.
19. Donadeu FX, Schauer SN (2013) Differential miRNA expression between equine ovulatory and anovulatory follicles. Domest Anim Endocrinol 45: 122-125.
20. Kiefel H, Bondong S, Hazin J, Ridinger J, Schirmer U, et al. (2012) L1CAM: A major driver for tumor cell invasion and motility. Cell Adh Migr 6: 374-384.
21. Schafer MK, Frotscher M (2012) Role of L1CAM for axon sprouting and branching. Cell Tissue Res 349: 39-48.
22. Schafer MK, Altevogt P (2010) L1CAM malfunction in the nervous system and human carcinomas. Cell Mol Life Sci 67: 2425-2437.
23. Grage-Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, et al. (2014) L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol 8: 982-997.
24. Schirmer U, Doberstein K, Rupp AK, Bretz NP, Wuttig D, et al. (2014) Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma. Oncotarget 5: 462-472.
25. Hoja-Lukowicz D, Link-Lenczowski P, Carpentieri A, Amoresano A, Pochec E, et al. (2013) L1CAM from human melanoma carries a novel type of N-glycan with Galbeta1-4Galbeta1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells. Glycoconj J 30: 205-225.
26. Held-Feindt J, Schmelz S, Hattermann K, Mentlein R, Mehdorn HM, et al. (2012) The neural adhesion molecule L1CAM confers chemo resistance in human glioblastomas. Neurochem Int 61: 1183- 1191.
27. Ito T, Yamada S, Tanaka C, Ito S, Murai T, et al. (2014) Over expression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer. Ann Surg Oncol 21: 560-568.
28. Chen DL, Zeng ZL, Yang J, Ren C, Wang DS, et al. (2013) L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer. J Hematol Oncol 6: 43.
29. Yi YS, Baek KS, Cho JY (2014) L1 cell adhesion molecule induces melanoma cell motility by activation of mitogen-activated protein kinase pathways. Pharmazie 69: 461-467.